Phenylephrine Shortage Update: What Patients Need to Know in 2026

If you've been searching for phenylephrine (Sudafed PE) at your local pharmacy in 2026 and coming up empty, you may be wondering: is there a phenylephrine shortage? The answer is more nuanced than a simple yes or no. Phenylephrine isn't in a traditional manufacturing shortage — the supply chain is intact. Instead, it's disappearing from shelves for a very different reason: the FDA has determined that oral phenylephrine doesn't work, and many retailers are removing it voluntarily.

Here's the full 2026 update on the phenylephrine situation — what happened, where things stand now, and what patients should do.

Is There an Official Phenylephrine Shortage in 2026?

No — phenylephrine is not on the FDA Drug Shortages database as a supply shortage. This means manufacturers are not having trouble making it, and there is no national shortage of raw materials or production capacity.

What IS happening is a regulatory-driven removal. The FDA is in the process of removing oral phenylephrine from the OTC monograph based on evidence that it doesn't work as a nasal decongestant. Until a final order is issued, oral phenylephrine can still legally be sold — but many pharmacies and retailers are getting ahead of the ruling by removing it from their shelves now.

Timeline: How We Got Here

Understanding the phenylephrine situation requires a bit of history:

• 2005: The Combat Methamphetamine Epidemic Act moved pseudoephedrine behind the pharmacy counter. Phenylephrine was reformulated into most OTC cold products as a replacement.
• 2007–2022: Multiple pharmacists and researchers raised concerns about oral phenylephrine's effectiveness. Citizen petitions were filed urging the FDA to re-evaluate it.
• September 2023: An FDA Nonprescription Drug Advisory Committee unanimously concluded that oral phenylephrine is not effective as a nasal decongestant at recommended OTC doses or higher doses.
• Late 2023–2024: CVS and other major chains voluntarily began removing single-ingredient oral phenylephrine products from open shelves. Consumer confusion and media coverage ramped up significantly.
• November 7, 2024: The FDA issued a formal proposed administrative order to remove oral phenylephrine from the OTC cold, cough, allergy, bronchodilator, and antiasthmatic drug products monograph.
• May 7, 2025: Public comment period closed. FDA is now reviewing comments before issuing a final order.
• 2026: A final FDA order could come in the second half of 2026. Once issued, manufacturers would have approximately one year to reformulate or remove products from the market.

Is Oral Phenylephrine Still Legal to Sell in 2026?

Yes. Until the FDA's proposed order becomes a final order, companies may continue to market and sell OTC drug products containing oral phenylephrine. Whether you can actually find it at your local pharmacy depends on what that specific store has chosen to stock.

What About Phenylephrine Nasal Spray and IV Phenylephrine?

The FDA's action only applies to oral (swallowed) phenylephrine as a nasal decongestant. Two other forms are completely unaffected:

• Phenylephrine nasal spray (Neo-Synephrine): Still considered effective and widely available. Delivers drug directly to nasal tissue. Limit use to 3 days to avoid rebound congestion.
• IV phenylephrine (Vazculep, Biorphen): Used in hospital settings to treat low blood pressure during anesthesia or septic shock. Not affected by the OTC ruling at all, and no shortage reported.

What Products Are Affected by the Phenylephrine Removal?

Hundreds of OTC products contain oral phenylephrine as an active ingredient, either as a single ingredient or in combination. Commonly affected products include:

• Sudafed PE (single-ingredient phenylephrine)
• DayQuil and NyQuil (some formulations)
• Mucinex Fast-Max (certain formulations)
• Benadryl Allergy Plus Sinus
• Alka-Seltzer Plus Cold products
• Robitussin Multi-Symptom Cold (some variants)

Note: For combination products, the FDA has confirmed that removing phenylephrine does not affect the effectiveness of the other active ingredients in the product (e.g., acetaminophen, dextromethorphan, guaifenesin).

What Should Patients Do Right Now?

Here are concrete steps patients can take in 2026:

1. Don't panic. Oral phenylephrine is not dangerous — the FDA's concern is about effectiveness, not safety. Your existing products are safe to use.
2. Talk to your pharmacist. Ask about pseudoephedrine (Sudafed) behind the counter, oxymetazoline nasal spray, or a corticosteroid spray like Flonase based on your symptoms.
3. Read labels carefully. Combination products like NyQuil may be reformulated over time. The Drug Facts label will always list all current active ingredients.
4. Use medfinder to locate medication. If you need a specific product and can't find it at your usual pharmacy, medfinder calls pharmacies near you to check availability and texts you the results.

Will Phenylephrine Come Back?

Oral phenylephrine in single-ingredient products is likely to disappear from store shelves permanently once the FDA's final order takes effect — expected no sooner than the second half of 2026, with manufacturers getting additional time after that to reformulate or discontinue products. Some combination cold products may reformulate by replacing phenylephrine with other active ingredients or removing it entirely. If you're looking for alternatives that work, check out our detailed guide to alternatives to phenylephrine for nasal congestion.